Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Vale SA — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Vale SA trades at $12.93 (market cap $56.46B). The key difference: Vale SA is far larger — about 14× Edgewise Therapeutics Inc. Common Stock's market cap, and Vale SA pays a 9.01% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Vale SA for 110 Days on average.
| EWTX | VALE | |
|---|---|---|
Market Cap | $4.02B | $56.46B |
Volume | 1,446,128 | 34,440,145 |
Sector | Health | Basic Materials |
52-Week High | $48.35 | $17.82 |
52-Week Low | $14.89 | $11.10 |
Typical Hold Time | 0 Days | 110 Days |
Enterprise Value | $3.56B | $72.71B |
Dividend Yield | — | 9.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VALE trades at $13.37, down 1.11% today, with a bearish technical signal and recent earnings misses. The company reported $38.4B revenue in 2025 with net income of $2.35B, though profit margins have compressed from 42.85% in 2022 to 6.12% in 2025. Analyst consensus is mixed with 32% buy ratings and a $15.93 price target, while recent news highlights cost pressures and regulatory risks in Brazil.
The outlook remains cautious due to cyclical exposure to iron ore prices and rising operational costs. While the base metals segment shows growth potential, near-term headwinds from margin compression and earnings volatility suggest limited upside. The stock offers a dividend yield but faces significant execution and commodity price risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
